Results 31 to 40 of about 507 (180)
Plants have long been considered a cost-effective platform for recombinant production. A recently recognized additional advantage includes the low risk of contamination of human pathogens, such as viruses and bacterial endotoxins. Indeed, a great advance
Shi-Jian Song +4 more
doaj +1 more source
Data_Sheet_1_Engineering the N-glycosylation pathway of Nicotiana tabacum for molecular pharming using CRISPR/Cas9.docx [PDF]
Molecular pharming in plants offers exciting possibilities to address global access to modern biologics. However, differences in the N-glycosylation pathway including the presence of β(1,2)-xylose and core α(1,3)-fucose can affect activity, potency and ...
Catherine Navarre (679322) +7 more
core +1 more source
Plant molecular pharming in Africa for sustainable health and economic development
Godwin Anywar +2 more
exaly +2 more sources
IL‐31 levels correlate with pruritus in patients with cholestatic and metabolic liver diseases Abstract Background and Aims Pruritus is associated with multiple liver diseases, particularly those with cholestasis, but the mechanism remains incompletely understood.
Jun Xu +20 more
wiley +1 more source
Antibody degradation in tobacco plants: a predominantly apoplastic process. [PDF]
BACKGROUND: Interest in using plants for production of recombinant proteins such as monoclonal antibodies is growing, but proteolytic degradation, leading to a loss of functionality and complications in downstream purification, is still a serious problem.
Hehle, VK +14 more
core +1 more source
Functionalizing silica sol–gel with entrapped plant virus-based immunosorbent nanoparticles
Advancements in understanding and engineering of virus-based nanomaterials (VBNs) for biomedical applications motivate a need to explore the interfaces between VBNs and other biomedically-relevant chemistries and materials.
Matthew J. McNulty +6 more
doaj +1 more source
Molecular pharming in plants and plant cell cultures: a great future ahead?
Plant biotechnology may not be a familiar concept to the general public, but it is a rapidly developing field of research that involves the use of plants, plant tissues and plant cell cultures to make or modify products and processes. The versatility of plants and plant cells can be harnessed to produce diverse products, including valuable proteins ...
Häkkinen, Suvi T. +3 more
openaire +2 more sources
Assessment of the immunogenicity of residual host cell protein impurities of OsrHSA. [PDF]
Human serum albumin (HSA) is the most abundant protein in human plasma and is widely used at high doses for treating various diseases. Recombinant HSA is an alternative approach to plasma-derived HSA, providing increased safety and an unlimited supply ...
Naghmeh Abiri +7 more
doaj +1 more source
Synthetic gene design—The rationale for codon optimization and implications for molecular pharming in plants [PDF]
ABSTRACTDegeneracy in the genetic code allows multiple codon sequences to encode the same protein. Codon usage bias in genes is the term given to the preferred use of particular synonymous codons. Synonymous codon substitutions had been regarded as “silent” as the primary structure of the protein was not affected; however, it is now accepted that ...
Gina R. Webster +2 more
openaire +2 more sources
Plant molecular farming (PMF) with tobacco could provide a sustainable and cheap platform for the production of high-value proteins for medical use. It could also offer European tobacco farmers an alternative, healthful end use for their crop.
Jonathan Menary +5 more
doaj +1 more source

